• English
  • Eesti
    NewsNews

    The Estonian medicinal products market in third quarter 2017

    14.11.2017
    Printer-friendly version

    Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

    Human medicines

    In the third quarter of 2017 the medicinal products market increased 1.7% reaching to 70.4 million euros. Estonian human medicines market of previous five years shows also an increasing trend:

    Sales to general pharmacies were 49.3 million euros, sales to hospital pharmacies 20.4 million euros and sales to other institutions 0.7 million euros.

    Prescription sales covered most of the medicinal products market, being 59.7 million euros. The turnovers of over the counter sales and hospital package sales were 10.2 million euros and 0.5 million euros.

    Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (15.5 million euros), alimentary tract and metabolism medicines (8.6 million euros) and antiinfectives for systemic use (8.2 million euros).

    Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

    According to DDD/1000/day the most consumed medicines in the third quarter of 2017 were cardiovascular system drugs (403 DDD/1000/day), alimentary tract and metabolism drugs (163 DDD/1000/day) and nervous system medicines (117 DDD/1000/day).

    The most consumed active substances were:

    INN

    DDD/1000/day

    Ramipril

    54,97

    Acetylsalicylic acid +Magnesium oxide

    49,82

    Amlodipine

    28,26

    Rosuvastatin

    27,49

    Ibuprofen

    26,15

    Omeprazole

    25,65

    Metoprolol

    23,95

    Telmisartan

    20,88

    Nebivolol

    20,14

    Metformin

    19,59

     

    In the third quarter of 2017, over 3600 different medicinal preparation packages and 1200 active substances were marketed in Estonia.

    Veterinary medicines

    The Estonian veterinary medicinal products market was 3.0 million euros in wholesale prices in the third quarter of 2017. Compared to the third quarter in 2016 the turnover increased 1.6%. 

    Almost 88% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 5% to the general pharmacies, 6% to the veterinary pharmacies and 1% to other institutions (generally state- and scientific institutions).

    The most sold medicines by turnover were antiinfectives for systemic use, antiparasitic products, immunologicals, alimentary tract and metabolism and musculo-sceletal products.